Trailblazer Acquisition Corp 最大收入來源為 Biocatalysts, Pharmaceutical Intermediates, and Codex Biocatalyst Panels and Kits,在最近的收益報告中收入為 70,387,000。就地區而言,United States 是 Trailblazer Acquisition Corp 的主要市場,收入為 43,537,000。
Trailblazer Acquisition Corp 是否盈利?
無,根據最新的財務報表,Trailblazer Acquisition Corp 的淨損失為 $0
Trailblazer Acquisition Corp 有負債嗎?
無,Trailblazer Acquisition Corp 的負債為 0
Trailblazer Acquisition Corp 的流通股有多少?
Trailblazer Acquisition Corp 的總流通股為 0
關鍵數據
前收市價
$10.21
開盤價
$10.21
當日範圍
$10.21 - $10.25
52週區間
$10 - $10.25
交易量
100
平均成交量
75.8K
股息收益率
--
每股盈餘 (TTM)
0.13
市值
$634.2M
什麼是 BLZRU?
Trailblazer Acquisition Corp. is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2025-09-10. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, or entities. The firm is focused on potential acquisition targets with primary operations in the media and communications, sports and entertainment, technology, and consumer retail sectors. The company has conducted no operations and has generated no revenue.